MGL is superior to DC-SIGN in the ability to generate IL-10 producing regulatory T cells after DCs stimulation (Hirata et al., 2016) and is mainly investigated for its role in tumor immunology (Valverde et al., 2020). Here, CLEC10A is linked to neoplasm.